| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 82 |
| 1 | ETANERCEPT | 24 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 22 |
| 3 | CONJUGATED ESTROGENS | 20 |
| 4 | ESTROGENS, CONJUGATED | 20 |
| 5 | LEVOTHYROXINE SODIUM | 20 |
| 6 | MEDROXYPROGESTERONE ACETATE | 20 |
| 7 | ADALIMUMAB | 18 |
| 8 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 16 |
| 9 | ASPIRIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, MENTHOL, AND METHYL SALICYLATE | 1 | 0.1250 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 22 | 0.0079 |
| 2 | ESTRADIOL AND NORETHINDRONE ACETATE | 2 | 0.0053 |
| 3 | PRAMOXINE HYDROCHLORIDE, MENTHOL | 1 | 0.0047 |
| 4 | COLLOIDAL OATMEAL | 1 | 0.0039 |
| 5 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 6 | OLODATEROL RESPIMAT INHALATION SPRAY | 1 | 0.0027 |
| 7 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 1 | 0.0017 |
| 8 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 9 | ESTROGEN | 3 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 35 |
| 1 | Estrogen [EPC] | 33 |
| 2 | Vitamin D [EPC] | 31 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 4 | Corticosteroid [EPC] | 21 |
| 5 | Vitamin C [EPC] | 18 |
| 6 | Benzodiazepine [EPC] | 17 |
| 7 | Aromatase Inhibitor [EPC] | 13 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 9 | Endothelin Receptor Antagonist [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Calcitonin [EPC] | 1 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 6 | 0.0002 |
| 5 | Estrogen [EPC] | 33 | 0.0002 |
| 6 | Progesterone [EPC] | 4 | 0.0002 |
| 7 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 8 | Non-narcotic Antitussive [EPC] | 2 | 0.0001 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 4 | 0.0001 |